The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification Consortium.

RATIONALE The 6-minute-walk distance (6MWD) test predicts mortality in chronic obstructive pulmonary disease (COPD). Whether variability in study type (observational vs. interventional) or region performed limits use of the test as a stratification tool or outcome measure for therapeutic trials is unclear. OBJECTIVES To analyze the original data from several large observational studies and from randomized clinical trials with bronchodilators to support the qualification of the 6MWD test as a drug development tool in COPD. METHODS Original data from 14,497 patients with COPD from six observational (n = 9,641) and five interventional (n = 4,856) studies larger than 100 patients and longer than 6 months in duration were included. The geographical, anthropometrics, FEV1, dyspnea, comorbidities, and health status scores were measured. Associations between 6MWD and mortality, hospitalizations, and exacerbations adjusted by study type, age, and sex were evaluated. Thresholds for outcome prediction were calculated using receiver operating curves. The change in 6MWD after inhaled bronchodilator treatment and surgical lung volume reduction were analyzed to evaluate the responsiveness of the test as an outcome measure. MEASUREMENTS AND MAIN RESULTS The 6MWD was significantly lower in nonsurvivors, those hospitalized, or who exacerbated compared with those without events at 6, 12, and greater than 12 months. At these time points, the 6MWD receiver operating characteristic curve-area under the curve to predict mortality was 0.71, 0.70, and 0.68 and for hospitalizations was 0.61, 0.60, and 0.59, respectively. After treatment, the 6MWD was not different between placebo and bronchodilators but increased after surgical lung volume reduction compared with medical therapy. Variation across study types (observational or therapeutic) or regions did not confound the ability of 6MWD to predict outcome. CONCLUSIONS The 6MWD test can be used to stratify patients with COPD for clinical trials and interventions aimed at modifying exacerbations, hospitalizations, or death.

[1]  Anders Larsson,et al.  Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.

[2]  R. Zuwallack,et al.  Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.

[3]  M. Puhan,et al.  Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. , 2016, The Cochrane database of systematic reviews.

[4]  B. Celli,et al.  The 6-min walk distance in healthy subjects: reference standards from seven countries , 2010, European Respiratory Journal.

[5]  K. Bailey,et al.  Prognostic value of treadmill exercise testing: a population-based study in Olmsted County, Minnesota. , 1998, Circulation.

[6]  Alan D. Lopez,et al.  Measuring the global burden of disease. , 2013, The New England journal of medicine.

[7]  G. Guyatt,et al.  Measuring functional status in chronic lung disease: conclusions from a randomized control trial. , 1989, Respiratory medicine.

[8]  M. Hyland,et al.  A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD. , 2001, Respiratory medicine.

[9]  E. Aksakal,et al.  Prognostic value of 6-minute walk test in stable outpatients with heart failure. , 2007, Texas Heart Institute journal.

[10]  G. Guyatt,et al.  Interpretation of treatment changes in 6-minute walk distance in patients with COPD , 2008, European Respiratory Journal.

[11]  F. D'Ovidio,et al.  Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. , 2006, American journal of respiratory and critical care medicine.

[12]  Sally J. Singh,et al.  Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement , 2016, European Respiratory Journal.

[13]  Richard D Riley,et al.  Individual participant data meta-analysis of prognostic factor studies: state of the art? , 2012, BMC Medical Research Methodology.

[14]  B. Celli,et al.  Validation and comparison of reference equations for the 6-min walk distance test , 2008, European Respiratory Journal.

[15]  D A Redelmeier,et al.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.

[16]  Thierry Troosters,et al.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.

[17]  M. Decramer,et al.  Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. , 2000, The American journal of medicine.

[18]  N. Ambrosino,et al.  Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs. , 2007, Respiratory medicine.

[19]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[20]  Thierry Troosters,et al.  An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.

[21]  Thierry Troosters,et al.  Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. , 2005, Archives of physical medicine and rehabilitation.

[22]  Stephen Burgess,et al.  Combining multiple imputation and meta-analysis with individual participant data , 2013, Statistics in medicine.

[23]  B. Celli,et al.  The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD , 2004, European Respiratory Journal.

[24]  R. Casaburi,et al.  The COPD Biomarker Qualification Consortium (CBQC) , 2013, COPD.

[25]  Edwin K Silverman,et al.  Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.

[26]  L. Edwards,et al.  Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. , 2013, American journal of respiratory and critical care medicine.

[27]  M. Varella‐Garcia,et al.  Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension. , 2010, American journal of respiratory and critical care medicine.

[28]  A. Ries,et al.  Effects of Pulmonary Rehabilitation on Physiologic and Psychosocial Outcomes in Patients with Chronic Obstructive Pulmonary Disease , 1995, Annals of Internal Medicine.

[29]  Y. Lacasse,et al.  Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. , 2007, Europa medicophysica.

[30]  Ulrike Held,et al.  Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index , 2009, The Lancet.

[31]  S. Sahn,et al.  Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. , 2011, American journal of respiratory and critical care medicine.

[32]  V. Pepin,et al.  Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[33]  B. Celli,et al.  Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. , 2002, Chest.

[34]  F. Martinez,et al.  The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema. , 2011, American journal of respiratory and critical care medicine.

[35]  R. Casaburi,et al.  Recommendations on the use of exercise testing in clinical practice , 2006, European Respiratory Journal.

[36]  D. Mannino,et al.  Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium. , 2016, American journal of respiratory and critical care medicine.

[37]  M. Tsukino,et al.  Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. , 2003, American journal of respiratory and critical care medicine.

[38]  Robert A Wise,et al.  Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. , 2003, American journal of respiratory and critical care medicine.

[39]  L. Fabbri,et al.  Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation , 2008, Thorax.

[40]  J. Myers,et al.  Exercise Capacity and Mortality in Black and White Men , 2008, Circulation.

[41]  A. Malhotra,et al.  Functional Capacity, Health Status, and Inflammatory Biomarker Profile in a Cohort of Patients With Chronic Obstructive Pulmonary Disease , 2015, Journal of cardiopulmonary rehabilitation and prevention.

[42]  L. Edwards,et al.  Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. , 2012, Journal of the American Medical Directors Association.

[43]  B. Celli,et al.  The 6-min walking distance: long-term follow up in patients with COPD , 2007, European Respiratory Journal.

[44]  B. Make,et al.  The minimal important difference of exercise tests in severe COPD , 2010, European Respiratory Journal.

[45]  B. Celli,et al.  Pulmonary rehabilitation and the BODE index in COPD , 2005, European Respiratory Journal.

[46]  L. Edwards,et al.  Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. , 2010, Respiratory medicine.

[47]  R. Zuwallack,et al.  Functional status and survival following pulmonary rehabilitation. , 2000, Chest.

[48]  D L Sherrill,et al.  Reference equations for the six-minute walk in healthy adults. , 1998, American journal of respiratory and critical care medicine.